I
NTLA
Intellia Therape
13.87
+0.32+2.36%After Hours: 13.87 0.00 0.00%16:10 04/08 EDT
OPEN/PREV CLOSE14.11/13.55
TODAY RANGE13.57-14.49
VOL3.01M
MARKET CAP1.64B
52 WEEK RANGE5.90-28.25
AVG VOL (3M)4.71M
% TURNOVER2.55%
TURNOVER--
P/E (TTM)-3.6423
% RANGE6.79%
EPS(TTM)-3.8080
P/E(FORWARD)-3.8209
P/B2.403
BVPS5.77
DIVIDEND--
P/S23.84
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.56B
SHARES OUTSTANDING118.13M
NEXT EARNINGS05/06-05/11
FREE FLOAT112.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·03/17 13:38
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value
Seeking Alpha·03/12 15:07
KalVista Pharmaceuticals: Has Potential But With Caveats
Seeking Alpha·03/09 20:07
Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take
Seeking Alpha·03/09 15:28
Intellia Therapeutics: Why The Clinical Hold Lift Isn't A Total Victory
Seeking Alpha·03/09 11:10
Cathie Wood's weekly recap: adds to AMZN, BABA, HOOD, COIN, cuts TSM, BIDU
Reuters·03/06 21:01
Intellia Therapeutics Awards 16,500 RSU Inducement Grants Under 2024 Plan
Seeking Alpha·03/05 15:05
Most and least shorted small-to-mid-cap stocks
TipRanks·03/04 23:06
Intellia Therapeutics (NTLA) Gets a Hold from Wedbush
TipRanks·03/04 14:41
Roblox initiated, Target upgraded: Wall Street’s top analyst calls
Benzinga·03/04 12:50
This Target Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
Dow Jones·03/04 12:28
Intellia Therapeutics Price Target Announced at $29.00/Share by Jones Trading
Same Industry
Name/Symbol
Change%
Price